These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 14778924)

  • 1. Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum.
    ARCHETTI I; HORSFALL FL
    J Exp Med; 1950 Nov; 92(5):441-62. PubMed ID: 14778924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic variants of influenza A virus (PR8 strain). II. Serological and immunological characteristics of variants derived from variants.
    GERBER P; HAMRE D; LOOSLI CG
    J Exp Med; 1956 Apr; 103(4):413-24. PubMed ID: 13306851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Persistent antigenic variations of influenza A virus after incomplete neutralization in ovo with heterologous immune serum].
    ARCHETTI I; HORSFALL FL
    Rend Ist Sup Sanit; 1951; 14(11):909-36. PubMed ID: 14930276
    [No Abstract]   [Full Text] [Related]  

  • 4. Antigenic variants of influenza A virus (PR8 strain). IV. Serological characteristics of a second line of variants developed in mice given polyvalent vaccine.
    HAMRE D; LOOSLI CG; GERBER P
    J Exp Med; 1958 Jun; 107(6):845-55. PubMed ID: 13539309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic variants of influenza A virus (PR8 strain) III. Serological relationships of a line of variants derived in sequence in mice given homologous vaccine.
    HAMRE D; LOOSLI CG; GERBER P
    J Exp Med; 1958 Jun; 107(6):829-44. PubMed ID: 13539308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic variants of influenza A virus, PR8 strain. I. Their development during serial passage in the lungs of partially immune mice.
    GERBER P; LOOSLI CG; HAMBRE D
    J Exp Med; 1955 Jun; 101(6):627-38. PubMed ID: 14367684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The experimental production of combination forms of virus. II. A study of serial passage in the allantoic sac of agents that combine the antigens of two distinct influenza A strains.
    HIRST GK; GOTLIEB T
    J Exp Med; 1953 Jul; 98(1):53-70. PubMed ID: 13069650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus.
    DAVENPORT FM; HENNESSY AV; FRANCIS T
    J Exp Med; 1953 Dec; 98(6):641-56. PubMed ID: 13109114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraepidemic heterogeneity of influenza A (H3N2) viruses in 1985: antigenic analysis and sensitivity to non-specific inhibitors.
    Pyhälä R; Pyhälä L; Visakorpi R
    Med Biol; 1986; 64(5):277-84. PubMed ID: 3807442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of identity in neutralizing and hemagglutination-inhibiting antibodies against influenza viruses.
    WALKER DL; HORSFALL FL
    J Exp Med; 1950 Jan; 91(1):65-86. PubMed ID: 15395574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic variants of influenza A virus (PR8 strain). V. Virulence, antigenic potency, and cross-protection tests in mice of the original and second series.
    LOOSLI CG; HAMRE D; GERBER P
    J Exp Med; 1958 Jun; 107(6):857-68. PubMed ID: 13539310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of influenza antibodies by serum absorption.
    JENSEN KE; DAVENPORT FM; HENNESSY AV; FRANCIS T
    J Exp Med; 1956 Aug; 104(2):199-209. PubMed ID: 13345965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift.
    Lambkin R; McLain L; Jones SE; Aldridge SL; Dimmock NJ
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3493-502. PubMed ID: 7527838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic heterogeneity within influenza A (H3N2) virus strains.
    de Jong JC; de Ronde-Verloop FM; Veenendaal-van Herk TM; Weijers TF; Bijlsma K; Osterhaus AD
    Bull World Health Organ; 1988; 66(1):47-55. PubMed ID: 3260141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of host cell-mediated variation on the international surveillance of influenza A (H3N2) viruses.
    Meyer WJ; Wood JM; Major D; Robertson JS; Webster RG; Katz JM
    Virology; 1993 Sep; 196(1):130-7. PubMed ID: 8356790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the antigenic patterns of influenza A virus strains determined by in ovo neutralization and hemagglutination-inhibition.
    HILLEMAN MR; HORSFALL FL
    J Immunol; 1952 Sep; 69(3):343-56. PubMed ID: 13000145
    [No Abstract]   [Full Text] [Related]  

  • 17. Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine-mediated immune protection.
    DeDiego ML; Anderson CS; Yang H; Holden-Wiltse J; Fitzgerald T; Treanor JJ; Topham DJ
    Immunology; 2016 Jun; 148(2):160-73. PubMed ID: 26854888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic studies of influenza viruses. I. Viral morphology and growth capacity as exchangeable genetic traits. Rapid in ovo adaptation of early passage Asian strain isolates by combination with PR8.
    KILBOURNE ED; MURPHY JS
    J Exp Med; 1960 Mar; 111(3):387-406. PubMed ID: 13755924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strain-specific elements in influenza antigens.
    HIRST GK
    J Exp Med; 1952 Dec; 96(6):589-603. PubMed ID: 13022853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.